ClinicalTrials.Veeva

Menu

The Efficacy of Si-Ni-Tang (a Chinese Herbal Formula) for Severe Sepsis

G

Guangdong Provincial Hospital of Traditional Chinese Medicine

Status

Completed

Conditions

Severe Sepsis

Treatments

Drug: Si-Ni-Tang

Study type

Interventional

Funder types

Other

Identifiers

NCT02777606
2014A020212280

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of Si-Ni-Tang (a Chinese Herbal Formula documented in Shang Han Lun) in treating severe sepsis.

Enrollment

50 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe sepsis (according to American college of chest Physicians/ Society of Critical Care Medicine (ACCP/SCCM) criteria)
  • Informed consent provided by patients or legally authorized representative
  • Yin syndrome in syndrome differentiation (according to principles of traditional Chinese medicine (TCM) syndrome differentiation)

Exclusion criteria

  • Pregnant or nursing female
  • Subject receiving immunosuppressive or immunoenhancement therapy in the past 3 months
  • Patients with known or suspicious autoimmune diseases
  • Patients not expected to survive 28 days due to end-stage disease or other uncorrectable medical condition
  • Fasting subjects
  • Known or suspicious allergy to any ingredient of Si-Ni-Tang
  • Patients not expected to survive 5 days for various reasons

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

Si-Ni-Tang (a Chinese Herbal Formula)
Experimental group
Description:
Treatment for severe sepsis adheres to the International guidelines for management of sepsis and septic shock 2012 and the Surviving Sepsis Campaign updated bundles in response to new evidence in 2015. Besides, 150ml of Si-Ni-Tang will be given by p.o. or a nasogastric tube once per day for 3 days in the treatment group.
Treatment:
Drug: Si-Ni-Tang
Control
No Intervention group
Description:
Treatment for severe sepsis adheres to the International guidelines for management of sepsis and septic shock 2012 and the Surviving Sepsis Campaign updated bundles in response to new evidence in 2015.

Trial contacts and locations

1

Loading...

Central trial contact

Rui-feng Zeng, Master; Yun Han, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems